GenomeFrontier Partners with BioCina for the Development and Manufacturing of GF-CART01 Cell Therapy Product DNA Materials For more information: https://www.prnewswire.com/news-releases/genomefrontier-selects-biocina-to-manufacture-minicircle-and-plasmid-dna-for-their-car-t-cell-therapy-product-301958160.html Share0